ES2140356A1 - Revitalizante natural. - Google Patents

Revitalizante natural.

Info

Publication number
ES2140356A1
ES2140356A1 ES009801739A ES9801739A ES2140356A1 ES 2140356 A1 ES2140356 A1 ES 2140356A1 ES 009801739 A ES009801739 A ES 009801739A ES 9801739 A ES9801739 A ES 9801739A ES 2140356 A1 ES2140356 A1 ES 2140356A1
Authority
ES
Spain
Prior art keywords
weight
revitalizer
natural
percentage
active component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009801739A
Other languages
English (en)
Other versions
ES2140356B1 (es
Inventor
Saura Manuel Castro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES009801739A priority Critical patent/ES2140356B1/es
Publication of ES2140356A1 publication Critical patent/ES2140356A1/es
Application granted granted Critical
Publication of ES2140356B1 publication Critical patent/ES2140356B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Revitalizante natural. El revitalizante natural comprende por lo menos un componente activo, que se caracteriza por el hecho de que dicho por lo menos un componente activo es una mezcla de romero en un porcentaje en peso comprendido entre 8 y 68%, preferiblemente 26,6% en peso, guaraná en un porcentaje en peso comprendido entre 12 y 72%, preferiblemente 33,3% en peso, y eleuterococo en un porcentaje en peso comprendido entre 20 y 80%, preferiblemente 40% en peso. Se trata de un complemento fisioenergético, especialmente contra el agotamiento físico, la impotencia sexual, alteraciones de la presión arterial, diferentes estados de depresión o problemas de stress en general.
ES009801739A 1998-08-12 1998-08-12 Revitalizante natural. Expired - Fee Related ES2140356B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES009801739A ES2140356B1 (es) 1998-08-12 1998-08-12 Revitalizante natural.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009801739A ES2140356B1 (es) 1998-08-12 1998-08-12 Revitalizante natural.

Publications (2)

Publication Number Publication Date
ES2140356A1 true ES2140356A1 (es) 2000-02-16
ES2140356B1 ES2140356B1 (es) 2000-09-16

Family

ID=8304887

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009801739A Expired - Fee Related ES2140356B1 (es) 1998-08-12 1998-08-12 Revitalizante natural.

Country Status (1)

Country Link
ES (1) ES2140356B1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1925313A1 (en) * 2006-11-24 2008-05-28 Nestec S.A. Prevention and treatment of disorders connected to impaired neurotransmission

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6049775A (ja) * 1983-08-29 1985-03-19 Sanyuu Shoji Kk 栄養食品の製造法
US4973467A (en) * 1989-10-13 1990-11-27 Natrol, Inc. Dietary supplement for adults
FR2687548A1 (fr) * 1992-02-20 1993-08-27 Bioes Laboratoires Nouvelle composition dietetique hypocalorique.
FR2712191A1 (fr) * 1993-11-08 1995-05-19 Bioes Laboratoires Composition pharmaceutique ou diététique associant du ginseng et du guarana.
GB2285578A (en) * 1993-12-22 1995-07-19 Leilani Lea Beverages containing added guaranine

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6049775A (ja) * 1983-08-29 1985-03-19 Sanyuu Shoji Kk 栄養食品の製造法
US4973467A (en) * 1989-10-13 1990-11-27 Natrol, Inc. Dietary supplement for adults
FR2687548A1 (fr) * 1992-02-20 1993-08-27 Bioes Laboratoires Nouvelle composition dietetique hypocalorique.
FR2712191A1 (fr) * 1993-11-08 1995-05-19 Bioes Laboratoires Composition pharmaceutique ou diététique associant du ginseng et du guarana.
GB2285578A (en) * 1993-12-22 1995-07-19 Leilani Lea Beverages containing added guaranine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN, PAJ CD-ROM, A21-24 (1976-1993) / 2, & JP 60049775 A (SANYUU SHOJI KK) *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1925313A1 (en) * 2006-11-24 2008-05-28 Nestec S.A. Prevention and treatment of disorders connected to impaired neurotransmission
WO2008062046A1 (en) * 2006-11-24 2008-05-29 Nestec S.A. Prevention and treatment of disorders connected to impaired neurotransmission
JP2010510293A (ja) * 2006-11-24 2010-04-02 ネステク ソシエテ アノニム 神経伝達障害と関係のある障害の予防及び処置
RU2455017C2 (ru) * 2006-11-24 2012-07-10 Нестек С.А. Профилактика и лечение расстройств, связанных с нарушенной нейротрансмиссией

Also Published As

Publication number Publication date
ES2140356B1 (es) 2000-09-16

Similar Documents

Publication Publication Date Title
BG101966A (en) Application of 1l-agonist for the treatment of lack of urine retention
BG101851A (en) Hepatitis vaccine
DE59410116D1 (de) Kombinationsprodukt zur kontrazeption enthaltend progesteronantagonisten und gestagenen
SG145698A1 (en) Methods of treating or preventing autoimmune diseases with 2,4- pyrimidinediamine compounds
MX9705235A (es) Inhibidores de calpaina y/o catepsina b de oxazolidina substituida.
BR0206644A (pt) Combinações de inibidor(es) de absorção de esteróis com agente(s) cardiovascular(es) para o tratamento de condições vasculares
ATE256435T1 (de) Implantat zum halten und/oder bilden eines zahnersatzes oder eines künstlichen fingergelenks
TW200500361A (en) Compositions, combinations, and methods for treating cardiovascular conditions and other associated conditions
AU2003288053A1 (en) Partially quaternised, amino-functional organopolysiloxanes and their use in aqueous systems
FI20012460A0 (fi) Putkiston haarakappale
ES1010119U (es) Pinza de doble boca.
ATE210149T1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
GB2331987B (en) Polycyclic sulphamate inhibitors of oestrone sulphatase
BG101232A (en) Bactericides
TWI268294B (en) High-uniformity spandex and process for making spandex
ES2140356A1 (es) Revitalizante natural.
MY120530A (en) Combination preparation for use in dementia
EP0318233A3 (en) Improvements in or relating to serotonin and norepinephrine uptake inhibitors
ATE360710T1 (de) Dentalguss-legierung
MXPA03000313A (es) Uso de fosfato de estramustina en el tratamiento de metastasis osea.
BR0104392A (pt) Anel de pistão e método de fabricar o mesmo
ATE200032T1 (de) In den menschlichen körper einführbares instrument
ATE382262T1 (de) Fungizide zusammensetzung auf der basis von saurem kaliumphosphit
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
MD1140B1 (en) Remedy possessing a regenerative and cytoprotective activity

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20000216

Kind code of ref document: A1

Effective date: 20000216

FD1A Patent lapsed

Effective date: 20050813